HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytogenetic assessment of Fanconi anemia in children with aplastic anemia in Tunisia.

AbstractBACKGROUND:
Chromosome breakage hypersensitivity to alkylating agents is the gold standard test for Fanconi anemia (FA) diagnosis. The aim of the present study was to assess the proportion of FA cases among aplastic anemia (AA) in Tunisian pediatric patients.
OBSERVATION:
Investigation of mitomycin C-induced chromosomal breakage was carried out in 163 pediatric patients with AA and siblings of the cases where diagnosis of FA was confirmed. We identified 31 patients with FA whose percentage of unstable mitoses ranges from 65% to 100%. Among 18 siblings who were investigated for chromosomal instability, 3 were incidentally found to be affected.
CONCLUSIONS:
FA is an important cause of AA in Tunisia. Our report is the first study in North Africa that explored cytogenetic and phenotypic findings in FA children. It also showed the importance of mitomycin C sensitivity screening in all FA siblings.
AuthorsFaten Talmoudi, Lobna Kammoun, Nizar Benhalim, Lamia Torjemane, Monia Ouederni, Lamia Aissaoui, Amel Lakhal, Fethi Mellouli, Tarek B Othmen, Mohamed Bejaoui, Sonia Abdelhak, Mounira Meddeb, Koussay Dellagi, Sondes Hdiji, Ahlem Amouri, Tunisian Fanconi Anemia Study Group
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 35 Issue 7 Pg. 547-50 (Oct 2013) ISSN: 1536-3678 [Electronic] United States
PMID23337544 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mitomycin
Topics
  • Adolescent
  • Anemia, Aplastic (complications, diagnosis, genetics)
  • Child
  • Child, Preschool
  • Chromosomal Instability
  • Chromosome Breakage (drug effects)
  • Consanguinity
  • Cytogenetic Analysis
  • Diagnosis, Differential
  • Fanconi Anemia (complications, diagnosis, genetics)
  • Female
  • Humans
  • Infant
  • Male
  • Mitomycin (pharmacology)
  • Tunisia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: